Minimally important differences for interpreting the EORTC QLQ‐C30 in patients with advanced colorectal cancer treated with chemotherapy

Aim The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ‐C30) assesses the health‐related quality of life of patients in cancer trials. There are currently no minimally important difference (MID) guidelines for the EORTC QLQ‐C30 for colorect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Colorectal disease 2020-12, Vol.22 (12), p.2278-2287
Hauptverfasser:	Musoro, J. Z., Sodergren, S. C., Coens, C., Pochesci, A., Terada, M., King, M. T., Sprangers, M. A. G., Groenvold, M., Cocks, K., Velikova, G., Flechtner, H.‐H., Bottomley, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced colorectal cancer Cancer Chemotherapy clinical anchors Clinical trials Colorectal cancer Colorectal carcinoma EORTC QLQ‐C30 health‐related quality of life (HRQOL) minimally important difference (MID) Patients Quality of life
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!